Bank of America
CMPX icon

Bank of America’s Compass Therapeutics CMPX Stock Holding History

Bank of America’s Portfolio CMPX Stock Details CMPX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.24M Sell
566,919
-298,694
-35% -$882K ﹤0.01% 4510
2026
Q1 		$4.58M Buy
865,613
+599,179
+225% +$3.46M ﹤0.01% 3536
2025
Q4 		$1.43M Buy
266,434
+192,633
+261% +$890K ﹤0.01% 4303
2025
Q3 		$258K Buy
73,801
+41,252
+127% +$130K ﹤0.01% 6156
2025
Q2 		$84.6K Sell
32,549
-350,954
-92% -$724K ﹤0.01% 6601
2025
Q1 		$729K Buy
383,503
+270,483
+239% +$719K ﹤0.01% 5444
2024
Q4 		$164K Buy
113,020
+30,303
+37% +$50.3K ﹤0.01% 6200
2024
Q3 		$152K Buy
82,717
+17,993
+28% +$22.4K ﹤0.01% 6148
2024
Q2 		$64.7K Buy
64,724
+19,310
+43% +$28.2K ﹤0.01% 6434
2024
Q1 		$89.9K Sell
45,414
-46,082
-50% -$79.6K ﹤0.01% 6294
2023
Q4 		$143K Sell
91,496
-22,662
-20% -$39.2K ﹤0.01% 6236
2023
Q3 		$225K Buy
114,158
+38,844
+52% +$96K ﹤0.01% 5846
2023
Q2 		$239K Sell
75,314
-18,666
-20% -$58.6K ﹤0.01% 5724
2023
Q1 		$307K Buy
93,980
+93,898
+114,510% +$369K ﹤0.01% 5685
2022
Q4 		$412 Buy
+82
New +$327 ﹤0.01% 7459
2022
Q2 		– Sell
-6
Closed – – 8054
2022
Q1 		$0 Buy
+6
New +$12 ﹤0.01% 8307

Other funds holding CMPX

TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OrbiMed
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
ES
Enavate Sciences Menlo Park, California $345M AUM 134.64% 1-Year Est. Return
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Bank of America's CMPX Position: Q2 2026 in Review

Bank of America reduced its Compass Therapeutics (CMPX) stake by 35% in Q2 2026, selling an estimated $882K and leaving 566,919 shares worth $1.24M. The position accounts for ﹤0.01% of the portfolio, ranked #4510.

Bank of America first reported a position in CMPX in Q1 2022 and has held it in 16 quarters since. The position peaked at $4.58M in Q1 2026. 215 funds tracked by Wall St. Rank hold CMPX as of Q2 2026.

  • Bank of America held 566,919 shares of Compass Therapeutics worth $1.24M as of Q2 2026.
  • Bank of America sold 298,694 Compass Therapeutics shares in Q2 2026, an estimated $882K.
  • Compass Therapeutics made up ﹤0.01% of Bank of America's portfolio in Q2 2026, its #4510 holding.
  • Bank of America first reported a position in Compass Therapeutics in Q1 2022 and has held it in 16 quarters since.
  • Bank of America's Compass Therapeutics position peaked at $4.58M in Q1 2026.
  • 215 funds tracked by Wall St. Rank held Compass Therapeutics as of Q2 2026.

Based on Bank of America's 13F filing for Q2 2026, filed 14 Aug 2026.